Uceris Uses

The prescription drug Uceris is used to treat a type of inflammatory bowel disease called ulcerative colitis. It is approved for use in adults only and works by decreasing inflammation. In some cases, healthcare providers may prescribe this drug to treat ulcerative colitis for longer than eight weeks; however, this is an unapproved use.

What Is Uceris Used For?

Uceris™ (budesonide ER) is a prescription medication approved for the treatment of ulcerative colitis. In particular, it is approved for treating mild-to-moderate active Crohn's disease for up to eight weeks to cause remission (improvement).
 
Ulcerative colitis is a type of inflammatory bowel disease (IBD) that leads to inflammation and ulcers in the lining of the large intestine and rectum. Common symptoms include diarrhea, abdominal (stomach) pain, and other symptoms like rectal bleeding or extreme urgency to have a bowel movement. At this time, the causes of ulcerative colitis are not fully understood.
 
Although ulcerative colitis complications can be quite severe, there is one ulcerative colitis cure -- surgery (see Ulcerative Colitis Surgery). However, because surgery is not for everyone, there are also nonsurgical ulcerative colitis treatment options, such as:
   
Although Uceris is not a cure for ulcerative colitis, it is quite useful for controlling flares of the disease. Ulcerative colitis often gets worse (these periods are known as flares) and improves (known as remission). Although continuous use of steroids, including Uceris, is not recommended, these medications are often necessary to get the disease under control.
 

Uceris Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.